AAPL $263.75 +1.24% MSFT $403.93 -0.93% GOOGL $303.58 -1.35% AMZN $208.73 +0.47% NVDA $180.05 +1.43% TSLA $392.43 -0.83% META $655.08 -1.32% JPM $300.26 -1.32% V $320.83 +0.00% WMT $127.91 +0.95% AAPL $263.75 +1.24% MSFT $403.93 -0.93% GOOGL $303.58 -1.35% AMZN $208.73 +0.47% NVDA $180.05 +1.43% TSLA $392.43 -0.83% META $655.08 -1.32% JPM $300.26 -1.32% V $320.83 +0.00% WMT $127.91 +0.95%

NASDAQ: TLRY

Tilray Brands, Inc.

Healthcare • Drug Manufacturers - Specialty & Generic • www.tilray.com

$7.36 $-0.24 (-3.16%)

As of Mar 4, 2:33 AM UTC

Key Statistics

Market Cap $946.21M
P/E Ratio -0.30
Dividend Yield 0.00%
Volume 4,029,842
Avg Volume 7,172,365
52-Week High N/A
52-Week Low N/A

About Tilray Brands, Inc.

Tilray is a Canadian producer that cultivates and sells medical and recreational cannabis. In 2021, legacy Aphria acquired legacy Tilray in a reverse merger and renamed itself Tilray. The bulk of its sales are in Canada and in the international medical cannabis export market. US exposure comes mainly from alcohol.

Analyst Ratings

View All →
N/A Based on 0 analysts
Avg Price Target $2.00 (-72.8% upside)

TLRY News

View All →

FEATURED BY